Pure Global AI
NCT05965882Recruiting

A Registry Study of Biomarkers in Ischemic Heart Disease ( BIOMS-IHD )

Beijing Institute of Heart, Lung and Blood Vessel DiseasesClinicalTrials.gov
Verified
Study focus
Disease/Condition
Cardiovascular Diseases
Study type
Observational
Sponsor & location
Primary sponsor
Beijing Institute of Heart, Lung and Blood Vessel Diseases
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2016
End date
Jun 01, 2024
Enrollment
5000 participants
Primary outcome

Number of hospitalizations for acute heart failure (HF)

Summary

The registry study aims to discover biomarkers for accurate classification and risk
 assessment of ischemic heart disease.

ICD-10 classifications
Cardiovascular disease, unspecifiedHypertensive heart diseaseOther ill-defined heart diseasesHeart disease, unspecifiedObservation for other suspected cardiovascular diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05965882
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05965882 through Pure Global AI's free database. This phase not specified trial is sponsored by Beijing Institute of Heart, Lung and Blood Vessel Diseases and is currently Recruiting. The study focuses on Cardiovascular Diseases. Target enrollment is 5000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.